Law.com Subscribers SAVE 30%
Call 855-808-4530 or email [email protected] to receive your discount on a new subscription.
Drug & Device News
Company Pays Heavy Penalty for Selling Adulterated Surgical Device
OtisMed Corp., maker of the OtisKnee guide, a device used by surgeons to make accurate cuts during knee surgeries, has pleaded guilty to selling unapproved medical devices. OtisMed, a Stryker subsidiary, and its former CEO entered their guilty pleas on Dec. 8, 2014. The company ageed at the same time to pay civil financial penalties that, along with the criminal fines levied against it, amount to more than $80 million. OtisMed also agreed it should be prevented from taking part in all federal programs for 20 years. Stryker will not be prosecuted, according to the parties' agreement, as long as OtisMed fulfills its obligations under the terms of the settlement within 90 days of sentencing.
The OtisKnee guide entered the market in 2006. Its maker sought marketing clearance from the Food and Drug Administration (FDA) in 2008, but that clearance was denied in 2009. A week later, the company shipped out more than 200 of the guides, thus introducing “adulterated medical devices” into interstate commerce, according to the government. Stryker did not acquire OtisMed until two months after the adulterated product shipments; according to the U.S. Attorney's Office, the parent company was unaware of OtisMed Corp.'s infractions until after it acquired the subsidiary.
Peter Harvey, attorney for convicted OtisMed CEO, was less than complimentary concerning the government's prosecution of the case. “What is extraordinary about this felony plea,” said Harvey, “is that the government has not penalized any current executive of Stryker Orthopedics, which owns OtisMed and … has accepted a plea from a Stryker subsidiary which has not had any employees, assets or revenues for the past three years.” He characterized his client's actions as “essentially a regulatory violation involving a product that posed no danger to the public,” explaining that the company's former CEO had shipped the guides after the FDA disapproved them only so that patients whose surgeries were imminent would not be “left hanging.”
'
Company Pays Heavy Penalty for Selling Adulterated Surgical Device
OtisMed Corp., maker of the OtisKnee guide, a device used by surgeons to make accurate cuts during knee surgeries, has pleaded guilty to selling unapproved medical devices. OtisMed, a Stryker subsidiary, and its former CEO entered their guilty pleas on Dec. 8, 2014. The company ageed at the same time to pay civil financial penalties that, along with the criminal fines levied against it, amount to more than $80 million. OtisMed also agreed it should be prevented from taking part in all federal programs for 20 years. Stryker will not be prosecuted, according to the parties' agreement, as long as OtisMed fulfills its obligations under the terms of the settlement within 90 days of sentencing.
The OtisKnee guide entered the market in 2006. Its maker sought marketing clearance from the Food and Drug Administration (FDA) in 2008, but that clearance was denied in 2009. A week later, the company shipped out more than 200 of the guides, thus introducing “adulterated medical devices” into interstate commerce, according to the government. Stryker did not acquire OtisMed until two months after the adulterated product shipments; according to the U.S. Attorney's Office, the parent company was unaware of OtisMed Corp.'s infractions until after it acquired the subsidiary.
Peter Harvey, attorney for convicted OtisMed CEO, was less than complimentary concerning the government's prosecution of the case. “What is extraordinary about this felony plea,” said Harvey, “is that the government has not penalized any current executive of Stryker Orthopedics, which owns OtisMed and … has accepted a plea from a Stryker subsidiary which has not had any employees, assets or revenues for the past three years.” He characterized his client's actions as “essentially a regulatory violation involving a product that posed no danger to the public,” explaining that the company's former CEO had shipped the guides after the FDA disapproved them only so that patients whose surgeries were imminent would not be “left hanging.”
'
This premium content is locked for Entertainment Law & Finance subscribers only
ENJOY UNLIMITED ACCESS TO THE SINGLE SOURCE OF OBJECTIVE LEGAL ANALYSIS, PRACTICAL INSIGHTS, AND NEWS IN ENTERTAINMENT LAW.
- Stay current on the latest information, rulings, regulations, and trends
- Includes practical, must-have information on copyrights, royalties, AI, and more
- Tap into expert guidance from top entertainment lawyers and experts
Already a have an account? Sign In Now Log In Now
For enterprise-wide or corporate acess, please contact Customer Service at [email protected] or 877-256-2473
How Secure Is the AI System Your Law Firm Is Using?
In a profession where confidentiality is paramount, failing to address AI security concerns could have disastrous consequences. It is vital that law firms and those in related industries ask the right questions about AI security to protect their clients and their reputation.
COVID-19 and Lease Negotiations: Early Termination Provisions
During the COVID-19 pandemic, some tenants were able to negotiate termination agreements with their landlords. But even though a landlord may agree to terminate a lease to regain control of a defaulting tenant's space without costly and lengthy litigation, typically a defaulting tenant that otherwise has no contractual right to terminate its lease will be in a much weaker bargaining position with respect to the conditions for termination.
Pleading Importation: ITC Decisions Highlight Need for Adequate Evidentiary Support
The International Trade Commission is empowered to block the importation into the United States of products that infringe U.S. intellectual property rights, In the past, the ITC generally instituted investigations without questioning the importation allegations in the complaint, however in several recent cases, the ITC declined to institute an investigation as to certain proposed respondents due to inadequate pleading of importation.
The Power of Your Inner Circle: Turning Friends and Social Contacts Into Business Allies
Practical strategies to explore doing business with friends and social contacts in a way that respects relationships and maximizes opportunities.
Authentic Communications Today Increase Success for Value-Driven Clients
As the relationship between in-house and outside counsel continues to evolve, lawyers must continue to foster a client-first mindset, offer business-focused solutions, and embrace technology that helps deliver work faster and more efficiently.